These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19924579)

  • 1. Mortality and drug exposure in a 5-year cohort of patients with chronic liver disease.
    Hug BL; Lipsitz SR; Seger DL; Karson AS; Wright SC; Bates DW
    Swiss Med Wkly; 2009 Dec; 139(51-52):737-46. PubMed ID: 19924579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
    Orman ES; Roberts A; Ghabril M; Nephew L; Desai AP; Patidar K; Chalasani N
    JAMA Netw Open; 2019 Jun; 2(6):e196412. PubMed ID: 31251379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
    Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
    Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.
    Jepsen P; Vilstrup H; Ott P; Keiding S; Andersen PK; Tygstrup N
    BMC Gastroenterol; 2009 Jun; 9():50. PubMed ID: 19566919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
    Zhang M; Wu R; Jiang J; Minuk GY; Niu J
    Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
    Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
    J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
    Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
    PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis.
    Pearson MM; Kim NJ; Berry K; Moon AM; Su F; Vutien P; Green PK; Williams EC; Ioannou GN
    Hepatol Commun; 2021 Dec; 5(12):2080-2095. PubMed ID: 34601829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study.
    Afify S; Eysa B; Hamid FA; Abo-Elazm OM; Edris MA; Maher R; Abdelhalim A; Abdel Ghaffar MM; Omran DA; Shousha HI
    World J Gastroenterol; 2021 Nov; 27(42):7362-7375. PubMed ID: 34876795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study.
    Su MH; Lu AL; Li SH; Zhong SH; Wang BJ; Wu XL; Mo YY; Liang P; Liu ZH; Xie R; He LX; Fu WD; Jiang JN
    World J Gastroenterol; 2015 Dec; 21(46):13087-94. PubMed ID: 26673249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
    Ye XG; Su QM
    World J Gastroenterol; 2013 Oct; 19(39):6665-78. PubMed ID: 24151397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark.
    Sørensen HT; Thulstrup AM; Mellemkjar L; Jepsen P; Christensen E; Olsen JH; Vilstrup H
    J Clin Epidemiol; 2003 Jan; 56(1):88-93. PubMed ID: 12589875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hepatotoxic drugs in chronic liver disease.
    Hug BL; Surber C; Bates DW
    J Patient Saf; 2012 Jun; 8(2):45-50. PubMed ID: 22525363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
    Bhala N; Angulo P; van der Poorten D; Lee E; Hui JM; Saracco G; Adams LA; Charatcharoenwitthaya P; Topping JH; Bugianesi E; Day CP; George J
    Hepatology; 2011 Oct; 54(4):1208-16. PubMed ID: 21688282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
    J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated care for patients with cirrhosis: fewer liver-related emergency admissions and improved survival.
    Ramachandran J; Hossain M; Hrycek C; Tse E; Muller KR; Woodman RJ; Kaambwa B; Wigg AJ
    Med J Aust; 2018 Sep; 209(7):301-305. PubMed ID: 30257622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis.
    Wu CC; Yeung LK; Tsai WS; Tseng CF; Chu P; Huang TY; Lin YF; Lu KC
    Clin Nephrol; 2006 Jan; 65(1):28-33. PubMed ID: 16429839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers in patients with decompensated cirrhosis.
    Prohić D; Mesihović R; Vanis N; Puhalović A
    Med Glas (Zenica); 2014 Feb; 11(1):99-104. PubMed ID: 24496348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.